Clinical Trial Update: Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

View source ↗

Summary

Clinical trial evaluating patient-derived organoids to observe the clinical consistency of personalized neoadjuvant therapy for resectable esophageal squamous c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Esophageal Cancer | Status: RECRUITING